@pierre77
Phase 2 trials to begin enrollment in the 2nd half of 2021. That has been announced at least twice, the first time being when they announced the Michael J Fox Foundation grant. The whole purpose of the BioMUSE study was to guide the design of the Phase 2 trials. So once the Phase 2 trials start the BioMUSE study is irrelevant in that regard.
I can't remember which announcement it was, but they were also looking at extending the BioMUSE study to run in parallel with the Phase 2 study, but I have not seen anything to suggest that is going to happen. This would presumably be to help with the design of Phase 3 trials.
So my original statement is in fact correct, and not misleading.
And perhaps you should pay more attention, you spelt my name wrong!!!
- Forums
- ASX - By Stock
- ATH
- Any news ??, up in NY 8%
Any news ??, up in NY 8%, page-14
-
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
|
|||||
Last
0.5¢ |
Change
0.001(11.1%) |
Mkt cap ! $26.22M |
Open | High | Low | Value | Volume |
0.4¢ | 0.5¢ | 0.4¢ | $14.25K | 2.930M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
66 | 81346070 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 19609447 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
63 | 79721070 | 0.004 |
53 | 53345564 | 0.003 |
15 | 38495514 | 0.002 |
15 | 94665101 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 19609447 | 23 |
0.006 | 34372301 | 14 |
0.007 | 18091596 | 18 |
0.008 | 14950875 | 15 |
0.009 | 6000000 | 5 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online